• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2017 年全球疾病负担研究:1990 年至 2017 年 2 型糖尿病导致的慢性肾脏病流行趋势变化。

Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017.

机构信息

Department of Nephrology, Kidney Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Department of Blood Purification, Kidney Hospital, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

J Diabetes Investig. 2021 Mar;12(3):346-356. doi: 10.1111/jdi.13355. Epub 2020 Aug 17.

DOI:10.1111/jdi.13355
PMID:32654341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7926234/
Abstract

AIMS/INTRODUCTION: Type 2 diabetes mellitus has been a leading cause of chronic kidney disease (CKD), with a heterogeneous distribution worldwide. Optimal healthcare planning requires an understanding of how the burden of CKD as a result of type 2 diabetes mellitus has changed over time and geographic location, as well as the potential roles of sociodemographic, clinical and behavioral factors in these changes.

MATERIALS AND METHODS

We used the Global Burden of Disease data from 1990 to 2017 at the global, regional and national levels to investigate changes in the incidence, death and disability-adjusted life years of CKD as a result of type 2 diabetes mellitus, incorporating both epidemiological research and risk factor monitoring.

RESULTS

The incident cases of CKD as a result of type 2 diabetes mellitus worldwide in 2017 had increased by 74% compared with 1990; total disability-adjusted life years had increased by 113%, mainly attributable to population expansion and demographic transition. The Sociodemographic Index was significantly and negatively correlated with overall CKD as a result of type 2 diabetes mellitus burden. However, in 82 countries and territories, the burden was not alleviated in parallel with socioeconomic development.

CONCLUSIONS

CKD as a result of type 2 diabetes mellitus has been the main contributor to the increasing burden of CKD over the past several decades. We suggest a more pragmatic approach focusing on early diagnosis, primary care and adequate follow up to reduce mortality and the long-term burden in low-to-middle Sociodemographic Index regions. Interventions should address high systolic blood pressure, as well as overweight and obesity problems, especially in high-income regions.

摘要

目的/引言:2 型糖尿病是慢性肾脏病(CKD)的主要病因,其在全球的分布存在差异。为了进行最佳的医疗保健规划,我们需要了解 2 型糖尿病导致的 CKD 负担随时间和地理位置的变化情况,以及社会人口学、临床和行为因素在这些变化中的潜在作用。

材料和方法

我们使用了全球疾病负担 1990 年至 2017 年的数据,在全球、区域和国家层面调查了 2 型糖尿病导致的 CKD 的发病率、死亡率和伤残调整生命年的变化情况,其中纳入了流行病学研究和风险因素监测。

结果

与 1990 年相比,2017 年全球 2 型糖尿病导致的 CKD 新发病例增加了 74%;总伤残调整生命年增加了 113%,主要归因于人口扩张和人口结构转变。社会人口学指数与 2 型糖尿病导致的 CKD 总负担呈显著负相关。然而,在 82 个国家和地区,2 型糖尿病导致的 CKD 负担并没有随着社会经济发展而得到缓解。

结论

过去几十年,2 型糖尿病导致的 CKD 一直是 CKD 负担增加的主要原因。我们建议采取更务实的方法,重点关注早期诊断、初级保健和充分随访,以降低中低收入社会人口学指数地区的死亡率和长期负担。干预措施应解决高血压和超重肥胖问题,特别是在高收入地区。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/ffe1c75b8117/JDI-12-346-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/bec605577362/JDI-12-346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/3262422b3b1a/JDI-12-346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/fc3695f73d47/JDI-12-346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/c7f5b0afc8ce/JDI-12-346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/07dc7fd7fa67/JDI-12-346-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/ffe1c75b8117/JDI-12-346-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/bec605577362/JDI-12-346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/3262422b3b1a/JDI-12-346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/fc3695f73d47/JDI-12-346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/c7f5b0afc8ce/JDI-12-346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/07dc7fd7fa67/JDI-12-346-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc6/7926234/ffe1c75b8117/JDI-12-346-g006.jpg

相似文献

1
Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017.2017 年全球疾病负担研究:1990 年至 2017 年 2 型糖尿病导致的慢性肾脏病流行趋势变化。
J Diabetes Investig. 2021 Mar;12(3):346-356. doi: 10.1111/jdi.13355. Epub 2020 Aug 17.
2
Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019.全球、区域和国家 1990 年至 2019 年与糖尿病相关的慢性肾脏病负担。
Front Endocrinol (Lausanne). 2021 Jul 1;12:672350. doi: 10.3389/fendo.2021.672350. eCollection 2021.
3
Temporal trends in prevalence and disability of chronic kidney disease caused by specific etiologies: an analysis of the Global Burden of Disease Study 2019.特定病因导致的慢性肾脏病患病率和残疾的时间趋势:2019 年全球疾病负担研究分析。
J Nephrol. 2024 Apr;37(3):723-737. doi: 10.1007/s40620-024-01914-x. Epub 2024 Mar 21.
4
Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20-59 years, 1990-2019.20-59 岁成年人 2019 年全球范围内归因于 2 型糖尿病的慢性肾脏病的负担及影响因素。
Sci Rep. 2023 Nov 19;13(1):20234. doi: 10.1038/s41598-023-47091-y.
5
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.《全球疾病负担研究》分析强调了 1990 年至 2016 年期间全球、地区和国家慢性肾脏病流行病学的趋势。
Kidney Int. 2018 Sep;94(3):567-581. doi: 10.1016/j.kint.2018.04.011. Epub 2018 Aug 3.
6
Disease Burden and Epidemiological Trends of Chronic Kidney Disease at the Global, Regional, National Levels from 1990 to 2019.1990 年至 2019 年全球、区域、国家各级别慢性肾脏病的疾病负担与流行病学趋势。
Nephron. 2024;148(2):113-123. doi: 10.1159/000534071. Epub 2023 Sep 15.
7
Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.全球、区域和国家层面归因于高空腹血糖的慢性肾脏病负担:来自 2019 年全球疾病负担研究的系统分析。
Front Endocrinol (Lausanne). 2024 Mar 27;15:1379634. doi: 10.3389/fendo.2024.1379634. eCollection 2024.
8
Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: An age-period-cohort analysis.全球归因于 2 型糖尿病的慢性肾脏病负担趋势:一项年龄-时期-队列分析。
Diabetes Obes Metab. 2024 Feb;26(2):602-610. doi: 10.1111/dom.15349. Epub 2023 Nov 7.
9
Epidemiological patterns of chronic kidney disease attributed to type 2 diabetes from 1990-2019.1990-2019 年归因于 2 型糖尿病的慢性肾脏病的流行病学模式。
Front Endocrinol (Lausanne). 2024 Apr 17;15:1383777. doi: 10.3389/fendo.2024.1383777. eCollection 2024.
10
Regional burden of chronic kidney disease in North Africa and Middle East during 1990-2019; Results from Global Burden of Disease study 2019.1990-2019 年北非和中东地区慢性肾脏病的区域负担;2019 年全球疾病负担研究结果。
Front Public Health. 2022 Oct 11;10:1015902. doi: 10.3389/fpubh.2022.1015902. eCollection 2022.

引用本文的文献

1
Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression.前瞻性快速糖尿病肾病进展的肾脏转录组学特征
BMC Nephrol. 2025 Aug 31;26(1):504. doi: 10.1186/s12882-025-04364-0.
2
Global burden and health inequalities of acute glomerulonephritis from 1990 to 2021: a systematic analysis of Global Burden Disease Study 2021.1990年至2021年急性肾小球肾炎的全球负担与健康不平等:全球疾病负担研究2021的系统分析
Ren Fail. 2025 Dec;47(1):2551731. doi: 10.1080/0886022X.2025.2551731. Epub 2025 Aug 31.
3
Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs.

本文引用的文献

1
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
2
Secondhand Smoke and CKD.二手烟与慢性肾脏病。
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):515-522. doi: 10.2215/CJN.09540818. Epub 2019 Mar 7.
3
The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps.
慢性肾脏病中糖尿病治疗药物的重新利用:钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂的作用机制、临床疗效及安全性
Pharmaceuticals (Basel). 2025 Jul 28;18(8):1130. doi: 10.3390/ph18081130.
4
The global incidence rate of type 2 diabetes related chronic kidney disease and predictions by Bayesian age-period-cohort analysis: findings from the Global Burden of Disease Study 2019.2型糖尿病相关慢性肾脏病的全球发病率及贝叶斯年龄-时期-队列分析预测:全球疾病负担研究2019的结果
Front Endocrinol (Lausanne). 2025 Aug 11;16:1429048. doi: 10.3389/fendo.2025.1429048. eCollection 2025.
5
Targeting to Intensify M2 Macrophage Polarization Ameliorate Podocyte Lipid Accumulation and Damage by Tea Polyphenols via Activating SIRT1 in the Aged Model Rats With DKD.靶向强化M2巨噬细胞极化通过激活老年糖尿病肾病模型大鼠的SIRT1改善足细胞脂质蓄积和损伤的茶多酚研究
Food Sci Nutr. 2025 Aug 11;13(8):e70736. doi: 10.1002/fsn3.70736. eCollection 2025 Aug.
6
The global, regional, and national prostate cancer burden and trends from 1990 to 2021, results from the global burden of disease study 2021.1990年至2021年全球、区域和国家前列腺癌负担及趋势,来自《2021年全球疾病负担研究》的结果
Front Public Health. 2025 May 21;13:1553747. doi: 10.3389/fpubh.2025.1553747. eCollection 2025.
7
Surrogate endpoints in diabetic kidney disease: current perspectives and future directions.糖尿病肾病中的替代终点:当前观点与未来方向。
Front Endocrinol (Lausanne). 2025 May 21;16:1557813. doi: 10.3389/fendo.2025.1557813. eCollection 2025.
8
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.2型糖尿病合并慢性肾脏病患者中SGLT2抑制剂或GLP-1受体激动剂新使用者队列的结局
Diabetes Ther. 2025 Jun 4. doi: 10.1007/s13300-025-01750-7.
9
Transitional changes in medication-initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes-A hospital-based cohort study in Japan.慢性肾脏病和2型糖尿病患者用药起始人群特征的过渡性变化——日本一项基于医院的队列研究
Diabetes Obes Metab. 2025 Jul;27(7):3714-3724. doi: 10.1111/dom.16394. Epub 2025 Apr 21.
10
A realist review of factors critical for the implementation of eHealth in chronic disease management.对慢性病管理中电子健康实施的关键因素进行的现实主义综述。
BMC Health Serv Res. 2025 Apr 2;25(1):496. doi: 10.1186/s12913-025-12361-0.
全球糖尿病肾病负担:时间趋势和性别差距。
Curr Diab Rep. 2019 Mar 2;19(4):18. doi: 10.1007/s11892-019-1133-6.
4
Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET).2015 年中国肾脏病网络(CK-NET)年度数据报告执行摘要。
Kidney Int. 2019 Mar;95(3):501-505. doi: 10.1016/j.kint.2018.11.011.
5
Kidney disease in the Global Burden of Disease Study 2017.《2017年全球疾病负担研究》中的肾脏疾病
Nat Rev Nephrol. 2019 Apr;15(4):193-194. doi: 10.1038/s41581-019-0120-0.
6
Cigarette smoking as a risk factor for diabetic nephropathy: A systematic review and meta-analysis of prospective cohort studies.吸烟作为糖尿病肾病的一个风险因素:一项前瞻性队列研究的系统评价和荟萃分析。
PLoS One. 2019 Feb 4;14(2):e0210213. doi: 10.1371/journal.pone.0210213. eCollection 2019.
7
Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project.全球肾病患者获取卫生技术和药物的情况:全球肾脏健康地图集项目的研究结果
Kidney Int Suppl (2011). 2018 Feb;8(2):64-73. doi: 10.1016/j.kisu.2017.10.010. Epub 2018 Jan 19.
8
Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system.全球肾脏病专业人才队伍:建立可持续肾脏护理体系的差距与机遇
Kidney Int Suppl (2011). 2018 Feb;8(2):52-63. doi: 10.1016/j.kisu.2017.10.009. Epub 2018 Jan 19.
9
Global Kidney Health Atlas (GKHA): design and methods.全球肾脏健康地图集(GKHA):设计与方法
Kidney Int Suppl (2011). 2017 Oct;7(2):145-153. doi: 10.1016/j.kisu.2017.08.001. Epub 2017 Sep 20.
10
Burden, access, and disparities in kidney disease.肾病的负担、可及性与差异
Kidney Int. 2019 Feb;95(2):242-248. doi: 10.1016/j.kint.2018.11.007.